ALK and non-small cell lung carcinoma: ALK rearrangements with other fusion partners have been described in various malignancies, such as anaplastic large-cell lymphoma (ALCL), non-small cell lung cancer (NSCLC), anaplastic thyroid carcinoma, and others [4].